Fig 6. DENV-DIII tetravalent vaccine formulation elicits DENV-specific neutralising antibodies.
A) Neutralisation and ADE of all four DENV serotypes, ZIKV, WNV and YFV, with pooled sera from mice vaccinated with the Tetra-DIII formulation (in all cases, for each virus-sera combination n = 3). B) FRNT50, as determined in (A), * indicates FRNT50 titres below detection limit of the assay (≥25).